Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation
about
Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel DiseaseRelevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver DiseaseLeptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individualsSustained Isoprostane E2 Elevation, Inflammation and Fibrosis after Acute Ischaemia-Reperfusion Injury Are Reduced by Pregnane X Receptor ActivationAdipokines and the role of visceral adipose tissue in inflammatory bowel diseaseAlleviation of gut inflammation by Cdx2/Pxr pathway in a mouse model of chemical colitisThe bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammationTranscriptional and Molecular Pathways Activated in Mesenteric Adipose Tissue and Intestinal Mucosa of Crohn's Disease Patients.Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4.Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis.Vitamin D/VDR, Probiotics, and Gastrointestinal DiseasesModulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTPProbiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitisMicrobiome and immunological interactions.VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation.The Role of the Mesentery in Crohn's Disease: The Contributions of Nerves, Vessels, Lymphatics, and Fat to the Pathogenesis and Disease Course.Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome.Cancer, inflammation, and insights from ayurveda.Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory DiseasesNutritional modulators of ulcerative colitis: clinical efficacies and mechanistic viewEffect of type of TAG fatty acids on lutein and zeaxanthin bioavailability.Probiotics and Nonalcoholic Fatty liver Disease.A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics.Nutritional and probiotic supplementation in colitis models.The new prophylactic strategy for colon cancer in inflammatory bowel disease by modulating microbiota.In vitro cell and tissue models for studying host-microbe interactions: a review.Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease.Probiotic supplementation and trimethylamine-N-oxide production following a high-fat diet.Efficacy of Bifidobacterium breve NCC2950 against DSS-induced colitis is dependent on bacterial preparation and timing of administration.Monitoring immune modulation by nutrition in the general population: identifying and substantiating effects on human health.Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment.Metabolic Variability of a Multispecies Probiotic Preparation Impacts on the Anti-inflammatory Activity.Effects of probiotic Lactobacillus rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS supplementation on intestinal and systemic markers of inflammation in ApoE*3Leiden mice consuming a high-fat diet.Inhibition of chronic ulcerative colitis-associated adenocarcinoma development in mice by VSL#3.Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rats with TNBS-induced colitis.Characterization of the fecal microbiota differs between age groups in Koreans.
P2860
Q26741117-0E64AE25-653C-400E-937C-D55E2A94A86DQ26778020-FC202455-70E7-4B7D-AD13-7018EB142DCEQ26859118-12FBCE15-83B7-4173-832A-D9E24287CC7DQ27322581-10F11670-6246-4501-8937-10A78C65218BQ28070229-2A93F7A4-273F-4EED-8207-F4781498042EQ28481350-E79277FE-3E45-4FD7-8646-0D14450B4887Q28585275-6414E50B-E1EC-4C08-9072-F1AAAAFFE738Q33592962-777848DC-8E77-42D6-B792-A9AA9CA4E179Q33684740-9C438FDD-BA55-4385-9816-E6FD291221FDQ33714116-5AC0CD39-C81B-4D5E-B6E2-672DD3742642Q33758617-87B5D5BB-7D99-48F9-8170-E45BF65650FAQ34155897-B4CF8D60-FFA3-44D0-80BC-2D21288DC1CCQ34170678-04804184-0A61-4B64-96B6-72CB31635300Q34292157-98F06ADF-52DF-47D4-9E27-C9DC7B906156Q34428997-25E94C87-81EA-496A-A2E5-F958757F6C68Q34526079-0F4D2574-CB58-43B8-A343-C45185ED152CQ34731103-A272CB63-9603-4F2F-8B31-086948C77CCCQ36100189-A9A7C343-20B4-4A7C-B607-60452B663BA1Q36449677-A28D658B-FEC4-47B2-9D53-710F69CA5C98Q36637753-A6FFECE7-82B1-4C0C-B41B-0AADE99CC574Q37072738-6DED6F3D-3885-4ACF-83DB-F2F54728062CQ37708418-F086AF9C-3BA7-4C33-9615-37E8887E2ED1Q37994645-C6D20A05-C10E-422F-9E58-3D5E04F6699CQ38021933-0D1BA356-ADF6-402E-8DE5-4D35CF5646E4Q38068230-0DBFACBE-D0BB-4826-80F8-087187BBC4DAQ38077630-CA712233-4650-4DA0-A06A-A1B059200B62Q38602706-8DC6BB80-E2B0-466C-9E7B-1A0F0AD7CB07Q38953644-1C7FA404-C2B8-4612-81D7-E0EFE0D77B7BQ39249472-728BF769-16EC-4E17-8136-FEB6087CB491Q39370979-423D6221-033C-4B03-960B-714FBF1B8D9AQ41158897-05F948C3-61F6-4B93-8E83-428C7CE148B7Q41159790-D8F8ACCF-4636-4022-AB46-AEB7695BB8CFQ50795525-A312F19E-E182-4855-BE79-8C9DD846C114Q53575927-33079771-DCB0-42AB-946F-A51BA6C124C1Q54508822-820B6194-8CDC-4708-AFA6-1F773D0335A0Q54965309-B68B3EC8-39DF-4B8B-9B00-EF663AB4778D
P2860
Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Probiotics modulate intestinal ...... iven adipose tissue activation
@ast
Probiotics modulate intestinal ...... iven adipose tissue activation
@en
Probiotics modulate intestinal ...... iven adipose tissue activation
@nl
type
label
Probiotics modulate intestinal ...... iven adipose tissue activation
@ast
Probiotics modulate intestinal ...... iven adipose tissue activation
@en
Probiotics modulate intestinal ...... iven adipose tissue activation
@nl
prefLabel
Probiotics modulate intestinal ...... iven adipose tissue activation
@ast
Probiotics modulate intestinal ...... iven adipose tissue activation
@en
Probiotics modulate intestinal ...... iven adipose tissue activation
@nl
P2093
P2860
P3181
P1433
P1476
Probiotics modulate intestinal ...... iven adipose tissue activation
@en
P2093
Andrea Mencarelli
Barbara Renga
Claudio D'Amore
Eleonora Distrutti
Giuseppe Palladino
Patrizia Ricci
Sabrina Cipriani
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0022978
P407
P577
2011-01-01T00:00:00Z